MedTrace Logo

Effects of ELAVl and CDOA vs Upper Thoracic Mobilization on Forward Head Posture in Upper Cross Syndrome

NCT06739889 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-12-18

No results posted yet for this study

Summary

This randomized controlled study will examine the patient of forward head posture who suffering with upper cross syndrome. There will be comparison of two treatment methods 1st one is elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA and 2nd is upper thoracic mobilization .

Conditions

  • Cross Syndrome

Interventions

DIAGNOSTIC_TEST

Elongation longitudinaux articular vertebral and columnar decoaption osteo-articulaire also known as ELDOA

ELDOA targtes cervical and upper thoracic spine. ELDOA exercises involves spicific postural holds that improve forward neck posture.The goal of ELDOA is to help reduce stress and increase space in the vertebral joints so that muscles can move freely. The benefits of these stretches include joint mobility, increased fluid absorption in the discs of the spine, flexibility, improved muscle tone, postural alignment, body-mind connection, and coordination. The tension and release created by these stretches helps normalize the posture.

DIAGNOSTIC_TEST

upper thoracic mobilization

Upper thoracic mobilization, often known as joint mobilization, is a common technique in manual therapy. In order to preserve or restore joint mobility, this approach glides and uses distraction on the joint surfaces.

Sponsors & Collaborators

  • Superior University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-09-01
Completion
2025-02-28

Countries

  • Pakistan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06739889 on ClinicalTrials.gov